Cargando…
Characterization of circRNAs in established osimertinib-resistant non-small cell lung cancer cell lines
Drug resistance is an urgent problem to be solved in the treatment of non-small-cell lung cancer (NSCLC). Osimertinib is a third-generation EGFR-tyrosine kinase inhibitor, which can improve the efficacy and quality of life of patients; however, the inevitable resistance after long-term use of osimer...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619537/ https://www.ncbi.nlm.nih.gov/pubmed/37681495 http://dx.doi.org/10.3892/ijmm.2023.5305 |